[关键词]
[摘要]
角膜病是我国主要的致盲性眼病之一,其中感染性角膜炎是角膜盲的主要原因。对于药物难以控制的角膜感染,角膜移植手术是控制感染,同时为患者复明的唯一希望。由于我国角膜供体严重匮乏,致使大多数患者在黑暗中苦苦等待,甚至丧失了眼球。因此,寻找新的角膜供体材料成为了眼科界研究的热点问题。近年来,生物工程角膜的研究取得了很大的进展。本文就已应用于临床的生物工程角膜基质的情况和生物角膜内皮的研究前景进行综述,探讨利用生物角膜代替人角膜供体应用于角膜移植手术的可行性。
[Key word]
[Abstract]
Corneal disease is one of the main ophthalmopathy that may lead to blindness in China. Infectious keratitis is the main cause of corneal blindness. For corneal infections that are difficult to control by drugs, corneal transplantation is the only hope to control the infection and restore the sight. However, the demand for suitable donor corneas is increasing much faster than the number of donors, leaving thousands of curable patients untreated and even lose their eyeballs. Thus, it's urgent to seeking new biomaterials for corneal donor. In recent years, there have come forward great progress in bioengineering cornea. Here, we reviews its application present in clinic and prospects for the future, exploring the feasibility of bioengineering cornea being the replacement of human corneal donor in corneal transplantation.
[中图分类号]
[基金项目]
四川省卫生和计划生育委员会科研课题(No.17PJ551)